THE WOODLANDS, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended September 30, 2024 and provided an ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

SGLT2 diabetes meds like Jardiance or Farxiga do the same ... Both are risk factors for heart attack and stroke. “Another ...

The SGLT2 medications canagliflozin ... which is a risk factor for heart attack and stroke. “Another mechanism that could be very important for this current study is that GLP-1 receptor agonists can ...

Empagliflozin, or Empa, is a medication often used to help people with type 2 diabetes manage their blood sugar. Now, ...

We believe that emphasize the differentiated asset sale for a broader label compared to SGLT2 inhibitors in a unique mechanism of action with dual SGLT1 inhibition potentially contributing to the ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

It's been over seven years since the Nintendo Switch first launched with its game-changing hybrid design. During its lifetime the Switch revitalised Nintendo's fortunes following the poor sales of ...